Enzo Biochem Inc (NYSE:ENZ)
$ 1.13 -0.04 (-3.42%) Market Cap: 57.88 Mil Enterprise Value: 4.83 Mil PE Ratio: 1.69 PB Ratio: 0.81 GF Score: 38/100

Q4 2021 Enzo Biochem Inc Earnings Call Transcript

Oct 12, 2021 / 12:30PM GMT
Release Date Price: $3.81 (-6.85%)
Operator

Greetings, and welcome to the Enzo Biochem Fourth Quarter and Full Year 2021 Financial Results and Business Update. (Operator Instructions) As a reminder, this conference is being recorded.

I'd now like to turn the conference over to your host, Bob Yedid of LifeSci Advisors. Thank you. You may begin.

Robert A. Yedid
LifeSci Advisors, LLC - MD

Thank you, Melissa, and good morning. Joining us today from the company are Barry Weiner, Co-Founder and President; and David Bench, Chief Financial Officer. News release announcing the results and the update was issued this morning and is available on the Enzo website.

I will now read the company's safe harbor statement. Except for historical information, the matters discussed in this news release may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities and Exchange Act of 1934 as amended. Such statements include declarations regarding the intent, belief or current expectations of the company and its

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot